STATCenter·
STAT+: Once again, child dies in gene-editing trial in China, rekindling debate on transparency and safety
With a second delayed report of a child's death in China, criticism is rising of a looser form of clinical trial. One expert: what "bothers me is the lack of…
Read at STAT →
